Zurich Cantonal Bank’s Janux Therapeutics JANX Stock Holding History

Zurich Cantonal Bank’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Buy	19,685 +7,328	+59%	+$106K	﹤0.01%	2178
2026 Q1	$172K	Sell	12,357 -180	-1%	-$2.47K	﹤0.01%	2282
2025 Q4	$173K	Hold	12,537	–	–	﹤0.01%	2270
2025 Q3	$306K	Sell	12,537 -67	-0.5%	-$1.63K	﹤0.01%	1984
2025 Q2	$291K	Buy	12,604 +5,479	+77%	+$144K	﹤0.01%	1975
2025 Q1	$192K	Buy	7,125 +1,488	+26%	+$56.1K	﹤0.01%	2119
2024 Q4	$302K	Buy	5,637 +2,028	+56%	+$107K	﹤0.01%	1940
2024 Q3	$164K	Hold	3,609	–	–	﹤0.01%	2218
2024 Q2	$151K	Buy	+3,609	New	+$169K	﹤0.01%	2180

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Zurich Cantonal Bank's JANX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Janux Therapeutics (JANX) stake by 59% in Q2 2026, buying an estimated $106K and bringing the position to 19,685 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

Zurich Cantonal Bank first reported a position in JANX in Q2 2024 and has held it in 9 quarters since. The position peaked at $306K in Q3 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Zurich Cantonal Bank held 19,685 shares of Janux Therapeutics worth $302K as of Q2 2026.
Zurich Cantonal Bank bought 7,328 Janux Therapeutics shares in Q2 2026, an estimated $106K.
Janux Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2178 holding.
Zurich Cantonal Bank first reported a position in Janux Therapeutics in Q2 2024 and has held it in 9 quarters since.
Zurich Cantonal Bank's Janux Therapeutics position peaked at $306K in Q3 2025.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.